Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Chemicals

Rating :
N/A

BSE: 532834 | NSE: CAMLINFINE

125.12
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  124.00
  •  129.05
  •  123.82
  •  124.57
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2236977
  •  2848.68
  •  139.70
  •  79.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,094.53
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,743.43
  • N/A
  • 3.25

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 48.02%
  • 5.46%
  • 34.52%
  • FII
  • DII
  • Others
  • 0.81%
  • 4.23%
  • 6.96%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.19
  • 8.98
  • 4.54

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.18
  • -16.48
  • -18.65

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.06
  • 38.33
  • 37.32

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.92
  • 2.88
  • 2.82

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 29.71
  • 15.42
  • 17.97

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
422.97
405.88
4.21%
395.85
419.60
-5.66%
401.69
426.71
-5.86%
385.89
387.83
-0.50%
Expenses
379.73
380.75
-0.27%
377.72
380.89
-0.83%
414.95
382.89
8.37%
362.56
338.08
7.24%
EBITDA
43.24
25.13
72.07%
18.14
38.71
-53.14%
-13.25
43.82
-
23.32
49.76
-53.14%
EBIDTM
10.22%
6.19%
4.58%
9.22%
-3.30%
10.27%
6.04%
12.83%
Other Income
12.10
1.76
587.50%
1.87
6.37
-70.64%
5.76
2.00
188.00%
1.66
9.76
-82.99%
Interest
26.42
19.78
33.57%
23.37
10.22
128.67%
16.17
9.78
65.34%
14.14
11.55
22.42%
Depreciation
20.69
19.20
7.76%
20.11
18.78
7.08%
20.05
17.93
11.82%
20.58
16.18
27.19%
PBT
-142.81
-12.08
-
-23.48
16.08
-
-93.51
8.43
-
-9.73
31.79
-
Tax
-26.20
8.74
-
11.17
4.06
175.12%
-11.72
4.95
-
4.55
8.92
-48.99%
PAT
-116.61
-20.83
-
-34.65
12.02
-
-81.78
3.48
-
-14.28
22.86
-
PATM
-27.57%
-5.13%
-8.75%
2.86%
-20.36%
0.82%
-3.70%
5.89%
EPS
-5.98
-1.16
-
-2.03
0.93
-
-4.61
0.58
-
-0.70
1.53
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
1,606.40
1,613.06
1,681.56
1,412.09
1,187.10
1,049.15
892.17
720.60
533.93
489.34
558.27
Net Sales Growth
-2.05%
-4.07%
19.08%
18.95%
13.15%
17.60%
23.81%
34.96%
9.11%
-12.35%
 
Cost Of Goods Sold
911.34
913.62
813.23
759.49
583.49
533.78
474.80
422.44
260.51
203.10
270.49
Gross Profit
695.06
699.44
868.33
652.59
603.62
515.37
417.36
298.16
273.42
286.24
287.78
GP Margin
43.27%
43.36%
51.64%
46.21%
50.85%
49.12%
46.78%
41.38%
51.21%
58.50%
51.55%
Total Expenditure
1,534.96
1,558.12
1,469.19
1,257.88
1,000.36
913.94
819.26
705.95
503.23
397.55
474.10
Power & Fuel Cost
-
124.31
204.60
123.01
86.08
76.38
80.42
61.43
46.35
47.43
58.00
% Of Sales
-
7.71%
12.17%
8.71%
7.25%
7.28%
9.01%
8.52%
8.68%
9.69%
10.39%
Employee Cost
-
178.75
162.62
145.05
120.38
99.71
87.89
72.87
61.09
40.05
40.58
% Of Sales
-
11.08%
9.67%
10.27%
10.14%
9.50%
9.85%
10.11%
11.44%
8.18%
7.27%
Manufacturing Exp.
-
114.58
107.12
75.93
81.09
50.73
41.56
34.70
31.04
37.04
35.06
% Of Sales
-
7.10%
6.37%
5.38%
6.83%
4.84%
4.66%
4.82%
5.81%
7.57%
6.28%
General & Admin Exp.
-
77.60
71.34
60.56
43.54
50.25
44.15
36.86
38.28
24.72
21.21
% Of Sales
-
4.81%
4.24%
4.29%
3.67%
4.79%
4.95%
5.12%
7.17%
5.05%
3.80%
Selling & Distn. Exp.
-
72.56
78.25
71.50
54.42
50.02
46.92
39.48
33.48
25.33
20.17
% Of Sales
-
4.50%
4.65%
5.06%
4.58%
4.77%
5.26%
5.48%
6.27%
5.18%
3.61%
Miscellaneous Exp.
-
76.70
32.02
22.34
31.36
53.06
43.52
38.17
32.48
19.88
20.17
% Of Sales
-
4.75%
1.90%
1.58%
2.64%
5.06%
4.88%
5.30%
6.08%
4.06%
5.12%
EBITDA
71.45
54.94
212.37
154.21
186.74
135.21
72.91
14.65
30.70
91.79
84.17
EBITDA Margin
4.45%
3.41%
12.63%
10.92%
15.73%
12.89%
8.17%
2.03%
5.75%
18.76%
15.08%
Other Income
21.39
44.19
6.44
36.66
10.79
3.43
13.79
12.91
15.65
4.27
8.38
Interest
80.10
69.97
66.24
40.80
48.14
47.63
40.95
31.80
30.58
24.44
23.82
Depreciation
81.43
78.61
62.51
55.96
44.29
32.80
28.99
26.65
21.80
17.06
16.25
PBT
-269.53
-49.44
90.06
94.11
105.10
58.20
16.75
-30.90
-6.03
54.57
52.48
Tax
-22.20
5.63
40.57
33.61
39.74
28.37
13.69
-6.75
-1.58
14.20
-2.21
Tax Rate
8.24%
-5.67%
50.47%
35.71%
37.81%
48.75%
81.73%
21.84%
26.20%
28.39%
-4.18%
PAT
-247.32
-92.76
52.11
60.68
50.97
30.32
0.63
-29.81
-11.20
35.82
55.04
PAT before Minority Interest
-223.60
-104.88
39.81
60.37
65.36
29.83
3.06
-24.14
-4.46
35.82
55.04
Minority Interest
23.72
12.12
12.30
0.31
-14.39
0.49
-2.43
-5.67
-6.74
0.00
0.00
PAT Margin
-15.40%
-5.75%
3.10%
4.30%
4.29%
2.89%
0.07%
-4.14%
-2.10%
7.32%
9.86%
PAT Growth
-1,510.84%
-
-14.12%
19.05%
68.11%
4,712.70%
-
-
-
-34.92%
 
EPS
-14.77
-5.54
3.11
3.62
3.04
1.81
0.04
-1.78
-0.67
2.14
3.29

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
864.75
819.37
747.93
643.40
403.14
370.88
371.16
212.58
176.22
134.87
Share Capital
16.75
15.71
15.70
12.75
12.13
12.13
12.12
10.37
9.67
9.59
Total Reserves
834.05
789.36
720.04
579.24
390.57
336.37
336.62
200.53
166.55
125.19
Non-Current Liabilities
322.00
413.05
403.40
257.81
185.44
154.88
72.63
32.51
11.69
16.84
Secured Loans
267.85
287.73
208.16
179.11
176.24
189.02
104.63
47.51
21.45
28.06
Unsecured Loans
64.87
120.36
179.49
94.14
35.27
4.62
5.61
3.81
0.00
0.00
Long Term Provisions
5.11
4.81
3.32
2.83
2.85
2.37
1.96
2.14
1.85
1.47
Current Liabilities
732.27
792.99
595.25
477.63
547.83
460.39
470.91
385.72
279.94
261.53
Trade Payables
324.64
288.35
233.78
158.40
173.72
164.61
177.79
78.40
95.31
106.55
Other Current Liabilities
164.41
246.62
164.44
92.55
81.51
43.92
39.04
27.45
27.40
19.50
Short Term Borrowings
233.46
233.28
181.01
216.90
278.07
244.34
246.79
269.90
145.70
120.95
Short Term Provisions
9.76
24.74
16.01
9.78
14.53
7.52
7.29
9.97
11.53
14.53
Total Liabilities
1,911.22
2,030.12
1,763.70
1,448.59
1,193.38
1,045.55
976.92
648.42
467.85
413.24
Net Block
816.35
857.62
601.21
581.45
303.71
272.44
278.10
200.88
140.27
106.43
Gross Block
1,177.88
1,124.42
829.89
758.39
428.21
359.11
342.34
213.71
359.66
295.11
Accumulated Depreciation
345.73
266.81
228.68
176.93
124.50
86.67
64.24
12.82
219.38
188.69
Non Current Assets
910.55
942.30
870.16
653.90
518.42
373.07
311.37
229.03
168.13
114.54
Capital Work in Progress
45.87
43.02
215.03
23.82
178.78
59.00
13.62
7.62
25.06
2.82
Non Current Investment
7.88
7.96
7.23
9.43
9.43
7.28
7.33
7.16
1.09
1.09
Long Term Loans & Adv.
39.70
31.55
42.35
37.30
24.84
32.06
11.31
7.73
1.70
4.21
Other Non Current Assets
0.77
2.16
4.34
1.90
1.65
2.29
1.01
5.62
0.00
0.00
Current Assets
998.60
1,085.75
891.47
794.69
674.96
672.48
665.55
419.40
299.72
298.69
Current Investments
0.00
0.00
0.00
0.00
0.00
3.25
108.08
11.70
0.00
0.00
Inventories
512.70
568.14
370.86
320.00
298.15
285.41
239.02
197.80
173.32
136.38
Sundry Debtors
285.15
304.59
299.68
270.71
252.80
209.32
205.35
144.89
75.48
113.42
Cash & Bank
93.53
99.23
142.14
138.34
64.79
103.44
48.08
31.24
18.90
19.26
Other Current Assets
107.21
19.28
18.67
23.80
59.21
71.05
65.02
33.77
32.03
29.63
Short Term Loans & Adv.
94.77
94.51
60.13
41.85
38.22
51.21
50.92
20.77
20.16
14.87
Net Current Assets
266.32
292.76
296.22
317.06
127.12
212.09
194.64
33.68
19.78
37.16
Total Assets
1,909.15
2,028.05
1,761.63
1,448.59
1,193.38
1,045.55
976.92
648.43
467.85
413.23

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
138.98
50.90
145.45
117.38
86.02
-9.00
-15.41
-8.69
71.57
46.26
PBT
-99.24
80.38
93.98
105.10
58.20
16.69
-30.90
-6.03
50.02
52.48
Adjustment
254.09
129.50
77.67
114.15
86.98
70.35
40.90
46.70
48.89
47.26
Changes in Working Capital
31.67
-138.79
4.17
-65.93
-41.25
-79.83
-15.27
-39.00
-15.14
-42.60
Cash after chg. in Working capital
186.52
71.09
175.82
153.32
103.94
7.22
-5.27
1.67
83.77
57.14
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-47.53
-20.20
-30.37
-35.93
-17.92
-16.22
-10.14
-10.36
-12.20
-10.88
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-66.50
-124.63
-249.13
-132.86
-90.12
-1.94
-148.59
-83.14
-65.67
-26.28
Net Fixed Assets
-44.20
-122.39
-222.00
-37.22
-149.41
-67.82
-7.46
57.11
-37.27
-23.68
Net Investments
1.93
-0.02
-6.14
0.45
-7.12
79.12
-104.14
-37.24
-2.13
-0.77
Others
-24.23
-2.22
-20.99
-96.09
66.41
-13.24
-36.99
-103.01
-26.27
-1.83
Cash from Financing Activity
-85.97
59.66
135.97
38.63
3.25
25.67
181.82
90.92
-6.87
-15.48
Net Cash Inflow / Outflow
-13.49
-14.07
32.29
23.15
-0.85
14.74
17.82
-0.92
-0.97
4.49
Opening Cash & Equivalents
93.74
107.81
75.52
52.37
53.21
38.48
20.65
8.03
8.99
4.50
Closing Cash & Equivalent
80.25
93.74
107.81
75.52
52.37
53.21
38.48
20.65
8.03
8.99

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
48.12
47.18
41.61
38.57
33.21
28.74
28.77
20.34
18.23
14.06
ROA
-5.32%
2.10%
3.76%
4.95%
2.66%
0.30%
-2.97%
-0.80%
8.13%
14.15%
ROE
-13.56%
5.71%
10.55%
14.61%
7.94%
0.88%
-8.63%
-2.30%
23.04%
48.31%
ROCE
-1.94%
10.38%
11.37%
15.25%
12.02%
7.32%
0.14%
5.45%
22.86%
28.50%
Fixed Asset Turnover
1.40
1.72
1.78
2.00
2.67
2.54
2.60
1.91
1.54
1.97
Receivable days
66.72
65.58
73.72
80.48
80.39
84.82
88.44
73.54
68.37
68.69
Inventory Days
122.29
101.91
89.29
95.03
101.51
107.28
110.30
123.85
112.09
78.55
Payable days
122.45
117.17
94.24
103.88
72.27
77.53
73.54
64.72
89.70
89.36
Cash Conversion Cycle
66.56
50.32
68.77
71.64
109.63
114.57
125.19
132.67
90.76
57.88
Total Debt/Equity
0.82
1.05
0.95
1.09
1.31
1.32
1.07
1.57
1.02
1.19
Interest Cover
-0.42
2.21
3.30
3.18
2.22
1.41
0.03
0.80
3.05
3.22

News Update:


  • Camlin Fine Sciences raises Rs 100 crore through NCDs
    6th Dec 2024, 09:30 AM

    The Securities Issue and Allotment Committee of the Company in its meeting held on December 5, 2024 has inter alia, approved the allotment of the same

    Read More
  • Camlin Fine Sciences gets nod for liquidation of CFS Pahang Asia
    11th Nov 2024, 16:25 PM

    The Liquidation is expected to be completed by March 31, 2025

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.